Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Apply
Xaluritamig, Darolutamide, Abiraterone
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step